Using COVID MyStudies for informed consent during the pandemic is easy for busy clinical trial teams: Contact FDA for eligibility, Coordinate with the COVID MyStudies Team, Use the App for your clinical trial https://t.co/LupqZzLixB
The COVID MyStudies App is a free platform for investigators to obtain informed consent securely from patients for eligible clinical trials when face-to-face contact is not possible or practical due to COVID-19 control measures https://t.co/tZewHLCdtK https://t.co/htr29vQucq
#ISPORannual session on Replication/Duplication of RCTs with RWE: review of the first 5 RWE studies from FDA/BWH Duplication initiative is underway https://t.co/LC2mLaOjwI
#FDAMyStudies webinar was attended by individuals from 60 countries on 6 continents...We will now work to support the new community growing around this open source platform...Stay tuned for a participatory event at FDA for developers and others who want to improve the platform
Learn about the open source FDA MyStudies mobile app and how to adapt and re-brand it in a "deep dive" FDA webinar on May 9. Recording and content will be posted 1 week later. https://t.co/1I79rKldwF https://t.co/0z9DotOiiu
A new open source configurable iOS and Android mobile app for clinical trials and real world evidence studies which was demonstrated at #AMIA2018 is available at https://t.co/U8P5Z7D5Ed.
Attending #AMIA2018? Stop by Yosemite A/B at 10:30am PST to see a live demo of the #FDA MyStudies app, a new mobile app designed to facilitate the capture of real world data directly from patients.